Blog

Ultragenyx Pharmaceutical RARE reported third-quarter 2025 loss of $1.81 per share, wider than the Zacks Consensus Estimate of a loss of $1.23. The company had incurred a loss of $1.40 per share in

Veritone VERI is set to report its third-quarter 2025 earnings on Nov. 6, after the bell.

The Zacks Consensus Estimate for VERI’s loss for the soon-to-be-reported quarter is pegged at 11 cents per

An updated edition of the Sept 12, 2025 article.

Unmanned aerial vehicles (UAVs), commonly known as drones, have emerged as one of the most transformative innovations in the dynamic landscape of

Madrigal Pharmaceuticals MDGL reported third-quarter 2025 loss of $5.08 per share, wider than the Zacks Consensus Estimate of a loss of $1.98. In the year-ago quarter, the company had incurred a

Altria Group, Inc.’s (MO) oral tobacco business delivered a standout margin performance in the third quarter of 2025, with adjusted operating company income margins rising 2.4 percentage points to

Harley-Davidson, Inc. HOG reported third-quarter 2025 adjusted earnings of $3.10 per share, which topped the Zacks Consensus Estimate of $1.38. The company had reported earnings of 91 cents per

Wednesday, November 5, 2025Like an oasis in the desert, this morning’s Automatic Data Processing ADP private-sector payroll report for October is out ahead of today’s opening bell. If these were

Novo Nordisk A/S NVO reported third-quarter 2025 earnings of 70 cents per American Depositary Receipt (ADR), which missed the Zacks Consensus Estimate of 77 cents. The company had reported earnings

Investors in Edwards Lifesciences Corporation EW need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 21, 2025 $50.00 Put had some of the

IPG Photonics IPGP reported third-quarter 2025 adjusted earnings of 35 cents per share, which beat the Zacks Consensus Estimate by 19 cents and climbed 9% year over year.Revenues of $250.8 million

Jack Henry & Associates (JKHY) reported first-quarter fiscal 2026 GAAP earnings of $1.97 per share, beating the Zacks Consensus Estimate by 20.1%. The figure jumped 20.9% year over year.

Jack Henry

Investors in Korn Ferry KFY need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 19, 2025 $50.00 Call had some of the highest implied

Investors in Element Solutions Inc. ESI need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 21, 2025 $17.50 Put had some of the highest

On Nov. 4, San Francisco, CA-based Uber Technologies UBER released rosy third-quarter 2025 results, wherein both earnings and revenues surpassed the Zacks Consensus Estimate. 

The question that

Investors in RXO, Inc. RXO need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 21, 2025 $7.50 Put had some of the highest implied volatility

The broader U.S. equity markets have witnessed a roller coaster ride over the past few days. This was due to strong quarterly performances by some blue-chip tech companies on one hand and concerns

Semiconductor companies are likely to have witnessed strong performance in the September-end quarter, driven by solid demand. The industry is continuing its dream run so far this year, which is

Hudson Pacific Properties (HPP) came out with quarterly funds from operations (FFO) of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to FFO of $0.1 per

Here is one stock with buy rank and strong momentum characteristics for investors to consider today, Nov. 5:

Flex Ltd. FLEX: This technology solutions company has a Zacks Rank #1 and witnessed the

McDonald's Corporation MCD reported mixed third-quarter 2025 results, wherein earnings missed the Zacks Consensus Estimate and revenues beat the same. On a year-over-year basis, the top line

Qualys QLYS came out with third-quarter 2025 earnings of $1.86 per share, beating the Zacks Consensus Estimate of $1.56 by 19.2%. The company reported earnings of $1.56 per share in the year-ago

Iron Mountain Incorporated IRM reported third-quarter adjusted funds from operations (AFFO) per share of $1.32, beating the Zacks Consensus Estimate of $1.29. This figure jumped 16.8% year over

Amicus Therapeutics FOLD reported adjusted earnings of 17 cents per share for the third quarter of 2025, which beat the Zacks Consensus Estimate of 12 cents. The company had reported adjusted

The Macerich Company MAC reported third-quarter 2025 funds from operations (FFO) per share of 35 cents, lagging the Zacks Consensus Estimate of 36 cents. The reported figure compares unfavorably

For Immediate Release

Chicago, IL – November 5, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and